Contentious hedge fund manager and activist investor Daniel Loeb is usually tight-lipped about the controversies that surround him. But at today’s New York Times DealBook Conference, Loeb dropped some bombs and addressed his critics, including George Clooney.
The controversial nutritional supplements company beat analysts’ expectations again but is still shelling out to fight the PR battle with its hedge fund antagonist.
In his quarterly investor letter, Ackman described D.A. Davidson analyst Timothy Ramey as “perennially bullish” on Herbalife and said that investors think he’s “speaking on behalf of the Company.” Ramey today said in a note that Ackman has capitulated and is at higher risk of losing his entire $1 billion short bet.
The embattled hedge fund manager and activist investor Bill Ackman detailed his investment failings and mistakes in a letter yesterday, despite his firm’s decent performance.
In a wide-ranging interview on PBS’ Charlie Rose show Tuesday night, Ackman defended his recent actions against J.C. Penney and himself against attacks from rivals.
UPDATED: A series of dramatic letters and erratic behavior by billionaire hedge fund manger Bill Ackman isn’t helping his activist investment efforts with J.C. Penney and Herbalife. His decision to resign from the board of J.C. Penney on Tuesday caps a year of public battles and strange moves, but is it too little, too late?
Herbalife, a dietary supplement company that has captured the intense focus of three of the hedge fund world’s most influential investors, continues to rake in capital, most recently from George Soros. Four, if you count Daniel Loeb.
Icahn is as well known for his fiery temper and pointed one-liners as he is for his hedge fund’s activist investing.
Some of Wall Street’s top companies have come under fire from investors fed up with their current management and financial performance and agitating for change. Call it the golden age of the activist.